Sponsor or institution
Clinical trials and research at Tata Memorial Centre
As of November 12, 2026, Find a Trial lists 37 clinical trials run by Tata Memorial Centre that are recruiting, in India. 1 was first registered in the last 30 days. By phase: Phase 2 (11), Phase 3 (4), Phase 1/2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 37Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (37)
-
Fewer-doses daratumumab added to VRd for newly diagnosed multiple myeloma
This study tests whether a less-frequent daratumumab dosing plan added to VRd can help patients with newly diagnosed multiple myeloma achieve more MRD negativity.
-
Withaferin A to help prevent graft-versus-host disease after stem cell transplant
This trial tests whether adding standardized Withaferin A to standard GvHD prevention can help people 18 and older with blood cancers who are getting a matched related donor stem cell transplant.
-
Lower Dose Cyclophosphamide After Haploidentical Stem Cell Transplant
This trial tests whether giving half the usual amount of cyclophosphamide after haploidentical stem cell transplantation can still prevent GVHD in adults with blood cancers.
-
Chlorophyllin to reduce mouth sores before allogeneic stem cell transplant
This phase II study tests whether taking chlorophyllin by mouth can lower the chances and severity of mouth ulcers in patients aged 12–65 undergoing radiation-based conditioning before a first allogeneic stem cell transplant.
-
Leflunomide to prevent CMV reactivation after haploidentical stem cell transplant
This study tests whether leflunomide can prevent CMV reactivation in adults undergoing haploidentical hematopoietic stem cell transplantation.
-
Standardized Withaferin A for steroid-refractory acute GVHD after stem cell transplant
This study tests whether a standardized extract of Withania somnifera (Withaferin A) given by mouth can help patients with steroid-refractory acute GVHD after an allogeneic stem cell transplant.
-
Immunonutrition for adults undergoing major hepatectomy
This study will test whether giving immunonutrition supplements around major liver surgery helps adults with liver tumors recover with fewer infections and shorter hospital stays.
-
PET-guided short-course higher-dose radiotherapy with temozolomide for poor-prognosis glioblastoma
This trial will try a shorter, higher-dose PET-guided radiotherapy schedule plus temozolomide in people aged 50 and older with poor-prognosis, IDH‑wildtype glioblastoma who are not candidates for surgery to see if it helps them live longer.
-
Intensity‑modulated proton versus photon radiation for children with benign or low-grade brain tumors
This trial will try intensity‑modulated proton therapy (IMPT) instead of standard photon IMRT to see if children aged 6–16 with benign or low‑grade brain tumors can get the same tumor control with fewer long‑term side effects.
-
68Ga‑FAPI PET/CT imaging for biliary tract cancers
We will test whether 68Ga‑FAPI PET/CT scans can find and stage gallbladder cancer and intrahepatic cholangiocarcinoma more accurately than standard FDG PET/CT in adults with suspected or known disease.
-
Home-based mobile neurological check for people with brain tumors
This project will test whether people with brain tumors older than 5 can use the Iskhaa Android app to do guided self-neurological exams, upload short videos, and have an AI model detect changes that might predict neurological worsening.
-
Trastuzumab plus chemotherapy versus chemotherapy alone for first-line HER2-positive advanced biliary tract cancer
This trial will test if adding trastuzumab to standard first-line chemotherapy helps people with HER2-positive advanced or metastatic biliary tract cancer control their disease longer than chemotherapy alone.
-
Daratumumab to clear leftover T‑cell acute lymphoblastic leukemia
This trial will try daratumumab given by IV to see if it can clear leftover cancer (MRD) in adults with T‑ALL who remain MRD‑positive after two induction cycles.
-
Comparing concurrent and sequential chemotherapy with radiation for breast cancer
This study is testing whether getting chemotherapy and radiation at the same time works better than getting them one after the other for people with stage IIB-III breast cancer.
-
Proton versus photon radiation for adults with primary brain tumors
This trial will test whether proton beam radiation causes fewer long-term side effects than standard photon (X-ray) radiation in adults aged 18–70 with primary brain tumors who are expected to live more than five years.
-
Shorter hormone therapy combined with radiotherapy for high-risk prostate cancer
This study is testing if a shorter hormone therapy combined with radiotherapy can help men with high-risk prostate cancer do better and feel better than the usual two-year hormone treatment.
-
Identifying biomarkers to predict cognitive decline after radiation therapy for brain tumors
This study is trying to find specific markers in blood and spinal fluid from young patients with brain tumors to see if they can predict problems with thinking and memory after radiation treatment.
-
Craniospinal irradiation for pediatric glioma treatment
This study is testing if a special type of radiation treatment can help kids with aggressive brain tumors live longer and have a better quality of life.
-
Database for managing rectal cancer patients with a watch-and-wait approach
This study is trying to gather information from rectal cancer patients in Asia who are closely monitored after treatment to see if the watch-and-wait approach is safe and effective for them.
-
Comparing two radiation therapies for anal canal cancer with chemotherapy
This study is testing whether a new type of radiation therapy called proton therapy works better than standard radiation therapy for people with anal canal cancer who are also getting chemotherapy, while trying to reduce side effects.
-
Glioma adaptive radiotherapy using an AI-driven dose plan
This trial tests whether using AI to guide adaptive radiation can improve treatment for adults with diffuse gliomas.
-
Comparing short and long-term use of levetiracetam for seizures in brain tumor patients
This study tests whether taking levetiracetam for a shorter time can help brain tumor patients with seizures just as well as the standard longer treatment.
-
Investigating brain tumors and their evolution
This study looks at brain tumors in patients of all ages to see how their locations and structures relate to the evolution of the brain and skull, using imaging data from thousands of past cases.
-
Using memantine to protect memory and cognition during craniospinal irradiation
This study is testing if the drug memantine can help protect memory and thinking skills in patients getting radiation treatment for brain tumors.
-
Comparing systemic therapy with and without radiation for unresectable gallbladder cancer
This study is testing whether adding radiation therapy to chemotherapy can help people with unresectable gallbladder cancer live longer and feel better.
-
Rifaximin to improve gut bacteria after allogeneic stem cell transplant for acute leukemia
This trial tests whether taking oral rifaximin around the time of an allogeneic stem cell transplant helps preserve healthy gut bacteria and reduces infections, graft‑versus‑host disease, and death in adults with acute leukemia.
-
Using artificial intelligence to improve radiation treatment for brain tumors
This study is testing whether using artificial intelligence can make radiation treatment for brain tumors more accurate and help doctors predict how well patients will respond to the treatment.
-
Analyzing brain tumors using advanced imaging techniques
This study is testing how advanced imaging techniques can help doctors better understand and classify gliomas, a type of brain tumor, by looking at past medical images from patients.
-
Using Chlorophyllin to Treat Brain Damage from Radiation in Glioma Patients
This study is testing if Chlorophyllin can help glioma patients with brain damage from radiation feel better and improve their quality of life.
-
Postoperative hypofractionated radiation for cervical and endometrial cancers
This study is testing a new type of radiation treatment after surgery for early-stage cervical and endometrial cancers to see how it affects patients' health and quality of life.
-
Evaluating breast appearance after cancer treatment using AI
This study tests whether using artificial intelligence to analyze photos can help doctors better understand how breast appearance changes after cancer treatment.
-
Comparing radiotherapy and observation for residual seminoma after chemotherapy
This study is testing whether giving radiotherapy or just watching closely is better for patients with advanced seminoma who still have leftover masses after chemotherapy.
-
Comparing gross examinations and frozen sections for surgical margins in oral cancers
This study is testing whether using frozen section analysis during surgery helps patients with oral cancer have better outcomes compared to just looking at the tissue with the naked eye.
-
Combining low dose craniospinal irradiation with focal radiotherapy for children with WNT medulloblastoma
This study is testing a new way to treat children with a specific type of brain tumor by using lower doses of radiation to see if it can help them get better while causing fewer side effects.
-
Low dose Bevacizumab with radiotherapy for DIPG patients
This study is testing if adding a low dose of Bevacizumab to regular radiotherapy can help newly diagnosed children with DIPG live longer and feel better based on how their tumors are behaving.
-
Evaluating post-mastectomy radiation for early breast cancer
This study tests if giving radiation after surgery can help women with early-stage breast cancer and certain high-risk factors avoid a return of their cancer.
-
Audit of surgery and chemotherapy for abdominal cancers
This study tests whether a combination of surgery and heated chemotherapy can help people with advanced colorectal and ovarian cancers live longer and feel better.
Quick answers
How many clinical trials run by Tata Memorial Centre are recruiting right now?
37, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in India. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 11, Phase 3: 4, Phase 1/2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.